HomeNEUP • NASDAQ
add
Neuphoria Therapeutics Inc
Previous close
$7.15
Day range
$6.67 - $7.35
Year range
$2.91 - $12.55
Market cap
12.92M USD
Avg Volume
22.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 15.00M | — |
Operating expense | 1.41M | 18.14% |
Net income | 11.26M | 505.38% |
Net profit margin | 75.08 | — |
Earnings per share | — | — |
EBITDA | 12.14M | 644.75% |
Effective tax rate | -0.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.04M | 68.20% |
Total assets | 30.71M | — |
Total liabilities | 4.72M | — |
Total equity | 26.00M | — |
Shares outstanding | 1.88M | — |
Price to book | 0.51 | — |
Return on assets | 122.46% | — |
Return on capital | 149.33% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 11.26M | 505.38% |
Cash from operations | 11.45M | 447.59% |
Cash from investing | — | — |
Cash from financing | 1.16M | -33.51% |
Net change in cash | 12.70M | 833.07% |
Free cash flow | 7.04M | — |
About
Founded
1996
Headquarters
Website
Employees
16
